BrightHeart View Classifier vs prolaio eVO2peak Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

BrightHeart View Classifier

by BrightHeart

prolaio eVO2peak Module

by Prolaio

AI Verdict

BrightHeart View Classifier focuses on real-time AI-powered guidance and analysis for prenatal ultrasound exams to detect congenital heart defects and ensure exam completeness. Prolaio eVO2peak Module, on the other hand, estimates peak oxygen consumption using real-world patient data from wearable sensors for cardiovascular research and care. While both are cardiology AI tools, their applications are in distinct areas of patient care and data acquisition.

Choose BrightHeart View Classifier if…

Choose BrightHeart View Classifier if your primary goal is to enhance the accuracy and completeness of prenatal fetal heart ultrasound exams, particularly for the early detection of congenital heart defects. This tool is ideal for OB/GYN and Maternal-Fetal Medicine specialists seeking real-time AI-powered guidance during scans and automated detection of standard cardiac views.

View BrightHeart View Classifier →

Choose prolaio eVO2peak Module if…

Choose Prolaio eVO2peak Module if you need to estimate peak oxygen consumption (eVO2peak) using real-world patient data from wearable sensors for cardiovascular research or clinical evaluation. This tool is best suited for cardiologists, physical medicine & rehab, and sports medicine specialists who require an adjunctive aid for assessing cardiopulmonary function without the need for traditional stress tests.

View prolaio eVO2peak Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	BrightHeart View Classifier	prolaio eVO2peak Module
Pricing	Not disclosed publicly.	Contact for pricing
Deployment	Cloud-based solution, integrates seamlessly into existing ultrasound workflows as a plug-and-play solution.	Cloud-based (software-only, processes remote sensor data)
FDA Status	Yes AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

BrightHeart View Classifier

BrightHeart View Classifier integrates seamlessly into existing ultrasound workflows as a plug-and-play solution and provides real-time guidance via a cart-side tablet, suggesting a highly integrated and user-friendly experience for sonographers during exams. Prolaio's eVO2peak Module processes data from remote sensors and wearable devices, which, while convenient for patients, may involve more steps for clinicians in data acquisition and integration into their existing systems.

Clinical Value

BrightHeart View Classifier

BrightHeart View Classifier offers AI-powered analysis of fetal heart ultrasound exams, automatically detecting standard views and flagging potential structural abnormalities suggestive of congenital heart defects, which are often missed in routine screenings. This directly addresses a critical diagnostic gap with high sensitivity and specificity. Prolaio's eVO2peak Module estimates peak oxygen consumption, providing adjunctive information for clinical evaluation in cardiovascular care and research, which is valuable but may not address as critical and immediate a diagnostic gap as BrightHeart's offering.

Pricing & Value

Tie

Neither BrightHeart View Classifier nor Prolaio eVO2peak Module publicly disclose their pricing, making a direct comparison of pricing and value impossible. Both require contacting the company for pricing details.

Enterprise Readiness

BrightHeart View Classifier

BrightHeart View Classifier is described as a cloud-based, plug-and-play solution that integrates seamlessly into existing ultrasound workflows and is compatible with major ultrasound manufacturers and existing reporting solutions. This indicates a strong focus on enterprise integration and scalability. Prolaio eVO2peak Module is also cloud-based and processes remote sensor data, but its enterprise readiness beyond data processing isn't as explicitly detailed in terms of integration with diverse hospital systems or large-scale deployment.

Innovation

BrightHeart View Classifier

BrightHeart View Classifier offers real-time guidance during prenatal ultrasound exams and automatic detection of standard fetal heart views, a novel approach to improve consistency and completeness regardless of operator experience. It also leverages advanced AI models like Meta's DINOv2 for accurate video classification. Prolaio's eVO2peak Module utilizes a locked deep-learning model to estimate peak oxygen consumption from real-world wearable data, which is innovative in its data collection and analysis, but BrightHeart's real-time interactive guidance during a complex imaging procedure appears to be a more significant workflow innovation.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer specific details regarding the level of customer support, training, or documentation available for either BrightHeart View Classifier or Prolaio eVO2peak Module. Therefore, it is not possible to determine a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	BrightHeart View Classifier	prolaio eVO2peak Module
Name	BrightHeart View Classifier	prolaio eVO2peak Module
Company	BrightHeart	Prolaio
Description	BrightHeart's B-Right AI Platform, including the B-Right Views tool, provides AI-powered guidance and analysis for prenatal ultrasound exams, enhancing the detection of congenital heart defects and ensuring exam completeness.	Prolaio is a clinical intelligence company that develops FDA-cleared software, such as the eVO2peak Module, to estimate peak oxygen consumption using real-world patient data for cardiovascular research and care.
Key Features	AI-powered analysis of fetal heart ultrasound exams, Real-time guidance during prenatal ultrasound exams via cart-side tablet, Automatic detection and confirmation of standard fetal heart views (B-Right Views), Flags potential structural abnormalities suggestive of congenital heart defects (B-Right Screen AI), Ensures exam completeness and consistency regardless of operator experience, Seamless integration into existing ultrasound workflows as a plug-and-play solution, Compatible with major ultrasound manufacturers and existing reporting solutions, Reduction in incomplete fetal heart scans and patient recall rates	Estimates peak oxygen consumption (eVO2peak), Utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs, Processes data from qualified third-party FDA-cleared wearable medical sensors, Applies a locked deep-learning model for eVO2peak estimation, Provides information as an adjunctive aid in clinical evaluation, Enables high-density, longitudinal data collection, Leverages real-world patient data and insights, Features FDA-cleared software and proprietary algorithms
Specialties	Cardiology, Maternal-Fetal Medicine, Obstetrics & Gynecology	Cardiology, Physical Medicine & Rehab, Sports Medicine

Videos

Demos, reviews, and walkthroughs featuring BrightHeart View Classifier and prolaio eVO2peak Module.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for a physician?

BrightHeart View Classifier is designed for seamless integration into existing ultrasound workflows, offering real-time guidance via a cart-side tablet and displaying results automatically. It's a plug-and-play solution compatible with major ultrasound manufacturers and existing reporting solutions, with detailed assessments available on a standalone web platform. Prolaio eVO2peak Module, being a software-only device, processes data from qualified third-party FDA-cleared wearable medical sensors, suggesting a workflow that involves patient use of these sensors and subsequent data processing in the cloud.

What is the depth of EHR integration for each tool, particularly concerning data transfer and reporting?

BrightHeart View Classifier is compatible with existing reporting solutions, summarizing results and linking them in reporting software, with detailed assessments accessible on a standalone web platform. Prolaio eVO2peak Module processes data from wearable sensors and provides information as an adjunctive aid in clinical evaluation, but public information does not specify direct, automated EHR integration beyond the processing of remote sensor data.

What are the reported accuracy and sensitivity metrics for each tool?

BrightHeart View Classifier has demonstrated a mean standard view recognition sensitivity of 0.939 and a mean standard view recognition specificity of 0.984. In a multi-center study, BrightHeart's AI achieved a sensitivity of 98.7% and specificity of 97.7% for detecting severe CHDs. The Prolaio eVO2peak Module met target accuracy, reliability/consistency, and bias criteria, with a mean error (bias) of 1.47 mL/kg/min and a mean absolute error of 4.39 mL/kg/min.

What is the learning curve for physicians and sonographers using these tools?

BrightHeart View Classifier is designed for seamless integration and provides real-time guidance via a cart-side tablet, aiming to ensure exam completeness and consistency regardless of operator experience, suggesting a reduced learning curve for sonographers. Prolaio eVO2peak Module processes data from wearable sensors, and while it lacks a user interface, Human Factors Engineering principles were applied to ensure safe integration and interpretation of outputs by clinical users, with documentation including instructions for integration and intended context of use.

What kind of support and resources are available for implementation and ongoing use?

BrightHeart has a Predetermined Change Control Plan (PCCP) approved by the FDA, allowing for efficient implementation of future AI improvements and product enhancements. Prolaio emphasizes its established regulatory and clinical foundation, and its platform is designed for long-term infrastructure, suggesting ongoing support for its technology and algorithms.

What are the audit-trail features for each tool to ensure accountability and review of AI-assisted findings?

BrightHeart View Classifier generates annotated DICOM files that cannot be modified by the user, and outputs are formatted as DICOM files compatible with any DICOM viewer, which would support an audit trail. Prolaio eVO2peak Module includes logging as part of its secure product development framework, which would contribute to audit-trail capabilities.

What clinical context helps differentiate these tools for a physician?

BrightHeart View Classifier is specifically designed for prenatal ultrasound exams to enhance the detection of congenital heart defects and ensure exam completeness, providing real-time guidance and flagging potential structural abnormalities. Prolaio eVO2peak Module estimates peak oxygen consumption using real-world patient data from wearable sensors, serving as an adjunctive aid in the clinical evaluation of adult patients for whom VO2 Peak cardiopulmonary functional testing is desired, without requiring a strenuous exercise test.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring BrightHeart View Classifier or prolaio eVO2peak Module

Backers

Who funded each tool's parent company.